IL89256A0 - Pharmaceutical compositions for preventing platelet loss containing a thromboxane a2 receptor antagonist and method for the preparation thereof - Google Patents

Pharmaceutical compositions for preventing platelet loss containing a thromboxane a2 receptor antagonist and method for the preparation thereof

Info

Publication number
IL89256A0
IL89256A0 IL89256A IL8925689A IL89256A0 IL 89256 A0 IL89256 A0 IL 89256A0 IL 89256 A IL89256 A IL 89256A IL 8925689 A IL8925689 A IL 8925689A IL 89256 A0 IL89256 A0 IL 89256A0
Authority
IL
Israel
Prior art keywords
thromboxane
preparation
pharmaceutical compositions
receptor antagonist
preventing platelet
Prior art date
Application number
IL89256A
Other languages
English (en)
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of IL89256A0 publication Critical patent/IL89256A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL89256A 1988-03-07 1989-02-10 Pharmaceutical compositions for preventing platelet loss containing a thromboxane a2 receptor antagonist and method for the preparation thereof IL89256A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/165,065 US4820733A (en) 1988-03-07 1988-03-07 Method of preventing or reducing platelet loss during extracorporeal circulation using a thromboxane A2 receptor antagonist

Publications (1)

Publication Number Publication Date
IL89256A0 true IL89256A0 (en) 1989-09-10

Family

ID=22597267

Family Applications (1)

Application Number Title Priority Date Filing Date
IL89256A IL89256A0 (en) 1988-03-07 1989-02-10 Pharmaceutical compositions for preventing platelet loss containing a thromboxane a2 receptor antagonist and method for the preparation thereof

Country Status (11)

Country Link
US (1) US4820733A (de)
EP (1) EP0332306A3 (de)
JP (1) JPH01272525A (de)
KR (1) KR890014117A (de)
AU (1) AU626829B2 (de)
CA (1) CA1334167C (de)
DK (1) DK106889A (de)
HU (1) HU208627B (de)
IL (1) IL89256A0 (de)
PH (1) PH25182A (de)
ZA (1) ZA891038B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4010536A1 (de) * 1990-04-02 1991-10-10 Boehringer Mannheim Gmbh Pharmazeutische waessrige loesung von 4-(2-(benzolsulfonylamino)-ethyl)-phenoxyessigsaeure

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3526362A1 (de) * 1985-07-19 1987-01-22 Schering Ag Prostacycline, ihre analoga oder prostaglandine und thromboxanantagonisten zur behandlung von thrombotischen und thromboembolischen krankheitsbildern

Also Published As

Publication number Publication date
AU3020889A (en) 1989-09-07
US4820733A (en) 1989-04-11
HU208627B (en) 1993-12-28
CA1334167C (en) 1995-01-31
EP0332306A2 (de) 1989-09-13
JPH01272525A (ja) 1989-10-31
KR890014117A (ko) 1989-10-21
PH25182A (en) 1991-03-27
ZA891038B (en) 1989-10-25
HUT49483A (en) 1989-10-30
DK106889A (da) 1989-09-08
EP0332306A3 (de) 1990-08-22
AU626829B2 (en) 1992-08-13
DK106889D0 (da) 1989-03-06

Similar Documents

Publication Publication Date Title
GR1002184B (en) Method for preparating intravenous pharmaceutical compositions
GB2222772B (en) Pharmaceutical compositions
GB2219940B (en) Pharmaceutical compositions
IL93996A0 (en) Pharmaceutical composition containing a liposome
IL72565A0 (en) Fast release pharmaceutical composition containing a dihydropyridine compound and processes for the preparation thereof
IL97513A0 (en) A pharmaceutical composition containing a thromboxane a2 receptor antagonist prostaglandin analog
ZA89958B (en) Pharmaceutical compositions containing lactams,new substituted lactams and processes for the preparation thereof
ZA895838B (en) Pharmaceutical compounds
IL102372A0 (en) Pharmaceutical composition containing a non-n-methyl-d-aspartate antagonist
PH25102A (en) Pharmaceutical compounds
HU896876D0 (en) Pharmaceutical compositions
IL90637A (en) Neurokinin a antagonists and pharmaceutical compositions containing them
GB2228922B (en) Packaging drugs
IL89256A0 (en) Pharmaceutical compositions for preventing platelet loss containing a thromboxane a2 receptor antagonist and method for the preparation thereof
ZA899948B (en) Pharmaceutical preparation
ZA89552B (en) Pharmaceutical composition for 4-aroylimidazol-2-ones
IL90219A0 (en) Hydrazinocarbonyloxylabdanes,a process for their preparation and pharmaceutical compositions containing them
GB2217202B (en) Trimelamol-containing pharmaceutical compositions
GB8830406D0 (en) Pharmaceutical compositions
IE890540L (en) Dispenser for powdered medication
IE882467L (en) Pharmaceutical preparation for external use
GB8817575D0 (en) Pharmaceutical preparation
GB8830078D0 (en) Pharmaceutical compounds
ZA893984B (en) Pharmaceutical compositions for piperidinoalkanol-ibuprofen combination
GB8815443D0 (en) Pharmaceutical compositions